MytoGen, a privately held biotech company involved in the development of cell-therapy products, took 24,940 sf at 79 – 96 Thirteenth St. in the Charlestown Navy Yard under a deal that significantly expands its presence at that location. The company previously subleased space in the facility.
Idera Pharmaceuticals, which develops therapeutics that modulate immune responses, took 26,589 sf at 167 Sydney St. in Cambridge. The deal gives the biotech firm a more efficient floor plan in a newly renovated and upgraded property.
Terms of both leases were not disclosed and phone calls soliciting additional information were not returned by GlobeSt.com's deadline.
The transactions were handled for the landlord by Cushman & Wakefield's Juliette Reiter, Mark Winters and David Townsend. The C&W team also represented both tenants. Joe Flaherty and Tucker Hansen, with Meredith & Grew assisted the landlord in the Idera transaction.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
